US experimental HIV vaccine regimen safe but ineffective: Study

Date:

A US investigational HIV vaccine regimen was safe but did not provide protection against HIV acquisition, according to a statement from the US National Institute of Health (NIH).

The trial, called HPX3002/HVTN 706 or “Mosaico,” began in 2019 and involved 3,900 volunteers aged between 18 to 60 years in Europe, North America, and South America, Xinhua news agency reported.

The trial was conducted by the HIV Vaccine Clinical Trials Network funded by the US National Institute of Allergy and Infectious Diseases, based at the Fred Hutchinson Cancer Research Centre in Seattle.

The experimental vaccine regimen was developed by Janssen. It was based on “mosaic” immunogens — vaccine components featuring elements of multiple HIV subtypes — with the goal of inducing immune responses against a wide variety of global HIV strains, according to the NIH on Wednesday.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

spot_img

Popular

More like this
Related

Telangana MLA Lasya Nanditha Dies in Road Accident, Political Leaders Offer Condolences

Telangana was struck by a wave of grief today...

Masthu Shades Unnai Ra Review | A Mixed Bag with Abhinav Debut Drama

Masthu Shades Unnai Ra Review Abhinav Gomatam steps out of...

Bootcut Balaraju OTT Release Date Locked | Steaming Details

Remember Bigg Boss star Sohel Ryan's romantic film "Bootcut...